Clinical Trial Update: Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial)

View source ↗

Summary

ClinicalTrials.gov entry for the IDPC trial comparing ioxaglate versus iodixanol to prevent contrast-induced nephropathy in high-risk patients; sponsor is Insti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• IODIXANOL (IODIXANOL)
• Ioxaglate (ioxaglate)

Snippet

Sponsor: Instituto Dante Pazzanese de Cardiologia | Conditions: Acute Kidney Failure | Status: UNKNOWN